Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Anergen, Organon to collaborate on RA treatment

July 5, 1996

ArQule obtains rights to Yale's alpha-ketoamide chemistry technology

July 5, 1996

Mitotix in-licenses p27 technology

July 5, 1996

Tripos' ChemSpace available for licensing soon

June 28, 1996

American Biogenetic Sciences obtains antibody technology from MRC

June 28, 1996

Collaboration for oral insulin formulation development

June 28, 1996

Techniclone's TNT to undergo clinical trials

June 28, 1996

Alizyme issued BTG license option

June 28, 1996

Hoechst, Hoechst Marion Roussel and Oncogene Science extend collaboration

June 28, 1996

Oxford Molecular Group and Alizyme begin research collaboration

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...